Market Overview

BMO Downgrades Ventas Citing 'The Donald Effect'

Share:
BMO Downgrades Ventas Citing 'The Donald Effect'

The surprise victory of Donald Trump as U.S. president has led to the downgrade of Ventas, Inc. (NYSE: VTR) to Underperform at BMO Capital Markets, which believes Trump’s opposition to the Affordable Care Act ("Obamacare") is bad for the sector.

Trump has vowed to "immediately deliver a full repeal of Obamacare." However, despite its backlash, the Affordable Care Act has greatly expanded health insurance coverage for many Americans, which allows more people to visit hospitals and MOBs.

Major ACA Changes 'Unfavorable'

“While the logistics of this may be challenging, we view a major change in the ACA as unfavorable to hospital operators, and secondarily, medical office buildings,” analyst John Kim wrote in a note.

Ventas, being a healthcare real estate investment trust (REIT), is exposed to both hospitals as well as medical office buildings (MOBs). Kim estimate 15 percent of Ventas’ NOI are in hospitals, the second highest in the healthcare REIT sector.

Ventas also has 19 percent exposure to MOBs, which has been a solid performer to date. However, the analyst raised his MOB cap rate for Ventas by 25bp to 5.97 percent due to this uncertainty.

Further, the decision of Kindred Healthcare, Inc. (NYSE: KND) to exit the skilled nursing business is negative for Ventas as the business accounts for 4 percent of Ventas' NOI out of the 9 percent from Kindred Healthcare.

“Ventas also has lower same-store growth than its peers, and faces rising supply in senior housing,” Kim added.

Kim cut the price target on Ventas shares to $55 from $65.

At time of writing, shares of Ventas fell 4.11 percent to $58.03.

Image Credit: By Careilly5801 (Own work) [CC BY-SA 4.0], via Wikimedia Commons

Latest Ratings for KND

DateFirmActionFromTo
Nov 2017Stifel NicolausUpgradesSellHold
Sep 2017Bank of AmericaMaintainsUnderperform
Aug 2017Deutsche BankMaintainsBuy

View More Analyst Ratings for KND
View the Latest Analyst Ratings

 

Related Articles (KND + VTR)

View Comments and Join the Discussion!

Posted-In: Analyst Color REIT Short Ideas Downgrades Health Care Price Target Politics Analyst Ratings Best of Benzinga

Latest Ratings

StockFirmActionPT
PECFRAMaintains8.0
HUNCFRAUpgrades16.0
CCCFRADowngrades11.0
VOYAPiper SandlerMaintains58.0
PRUPiper SandlerMaintains64.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com